These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7766726)

  • 1. Identification of four plasma metabolites of Etoperidone in dogs.
    Wu WN; Masucci JA; McKown LA; Rodgers JD
    J Pharm Biomed Anal; 1995 Feb; 13(2):177-84. PubMed ID: 7766726
    [No Abstract]   [Full Text] [Related]  

  • 2. Gas--liquid chromatographic determination of etoperidone in plasma, serum, and urine.
    Gilmour WJ; Leary JR
    J Chromatogr; 1982 Dec; 233():381-5. PubMed ID: 7161352
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man.
    Caldwell GW; Wu WN; Masucci JA
    Xenobiotica; 2001 Nov; 31(11):823-39. PubMed ID: 11765144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay with ultraviolet detection for the determination of etoperidone and two active metabolites, 5-(1-hydroxyethyl) etoperidone and 1-(3-chlorophenyl)piperazine, in plasma.
    Holland ML; Heebner ET
    J Chromatogr; 1991 Jul; 567(2):433-40. PubMed ID: 1939475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas chromatographic-mass spectrometric method for trazodone and a deuterated analogue in plasma.
    Gammans RE; Kerns EH; Bullen WW; Covington RR; Russell JW
    J Chromatogr; 1985 May; 339(2):303-12. PubMed ID: 4008570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.
    Choong E; Rudaz S; Kottelat A; Haldemann S; Guillarme D; Veuthey JL; Eap CB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1544-50. PubMed ID: 21524943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity.
    Raffa RB; Shank RP; Vaught JL
    Psychopharmacology (Berl); 1992; 108(3):320-6. PubMed ID: 1387963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC analysis of the antidepressant trazodone and its main metabolite m-CPP in human plasma.
    Mercolini L; Colliva C; Amore M; Fanali S; Raggi MA
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):882-7. PubMed ID: 18400445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone.
    Melzacka M; Rurak A; Vetulani J
    Pol J Pharmacol Pharm; 1980; 32(4):551-6. PubMed ID: 7255270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changed plasma prolactin levels after etoperidone and placebo.
    Meco G; Casacchia M; Boni B; Cusimano G; Carta A; Iannuccelli M
    Int J Clin Pharmacol Res; 1984; 4(2):117-20. PubMed ID: 6469437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection.
    Martínez MA; Sánchez de la Torre C; Almarza E
    J Anal Toxicol; 2004 Apr; 28(3):174-80. PubMed ID: 15107147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cardiovascular toxicity of trazodone, etoperidone and imipramine in rats.
    Lisciani R; Baldini A; Benedetti D; Campana A; Barcellona PS
    Toxicology; 1978 Jun; 10(2):151-8. PubMed ID: 684760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of trazodone in serum by instrumental thin-layer chromatography.
    Siek TJ
    J Anal Toxicol; 1987; 11(5):225-7. PubMed ID: 3682783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorimetric determination of fluvoxamine or clovoxamine in human plasma after thin-layer chromatographic or high-performance liquid chromatographic separation.
    Schweitzer C; Spahn H; Mutschler E
    J Chromatogr; 1986 Oct; 382():405-11. PubMed ID: 3097046
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine.
    Cioli V; Corradino C; Piccinelli D; Rocchi MG; Valeri P
    Pharmacol Res Commun; 1984 Jan; 16(1):85-100. PubMed ID: 6701182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of conditioned avoidance responding by trazodone, etoperidone, and MCPP.
    Martin GE; Mathiasen JR; Kesslick JM
    Psychopharmacology (Berl); 1989; 99(1):94-7. PubMed ID: 2506609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
    Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
    Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects and the "blindability" of clinical drug trials.
    White K; Kando J; Park T; Waternaux C; Brown WA
    Am J Psychiatry; 1992 Dec; 149(12):1730-1. PubMed ID: 1443253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-chromatographic determination of two antidepressants, trazodone and mianserin, in plasma.
    Wong SH; Waugh SW; Draz M; Jain N
    Clin Chem; 1984 Feb; 30(2):230-3. PubMed ID: 6692527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorimetric determination of levoprotiline in human plasma after thin-layer chromatographic or high performance liquid chromatographic separation.
    Horne C; Spahn H; Mutschler E
    Arzneimittelforschung; 1987 Oct; 37(10):1179-81. PubMed ID: 3435591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.